Update on systemic treatment for newly diagnosed inflammatory breast cancer

BACKGROUND: Inflammatory breast cancer (IBC) is a rare and aggressive disease, accounting for 2–4% of new cases of breast cancer. Owing to its aggressive nature, IBC represent approximately 8–10% of breast cancer deaths. Management of IBC requires a multidisciplinary team for decision-making involvi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chainitikun, Sudpreeda, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020152/
https://www.ncbi.nlm.nih.gov/pubmed/33842000
http://dx.doi.org/10.1016/j.jare.2020.08.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020152/
https://www.ncbi.nlm.nih.gov/pubmed/33842000
http://dx.doi.org/10.1016/j.jare.2020.08.014

Ejemplares similares